vs
Side-by-side financial comparison of HERTZ GLOBAL HOLDINGS, INC (HTZ) and Kenvue (KVUE). Click either name above to swap in a different company.
Kenvue is the larger business by last-quarter revenue ($3.8B vs $2.0B, roughly 1.9× HERTZ GLOBAL HOLDINGS, INC). Kenvue runs the higher net margin — 8.7% vs -9.6%, a 18.3% gap on every dollar of revenue. On growth, Kenvue posted the faster year-over-year revenue change (3.2% vs -0.6%). Over the past eight quarters, HERTZ GLOBAL HOLDINGS, INC's revenue compounded faster (-1.3% CAGR vs -1.5%).
Hertz Global Holdings, Inc., known as Hertz, is an American car rental company based in Estero, Florida. The company operates its namesake Hertz brand, along with the brands Dollar Rent A Car, Firefly Car Rental, and Thrifty Car Rental.
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
HTZ vs KVUE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $3.8B |
| Net Profit | $-194.0M | $330.0M |
| Gross Margin | — | 56.5% |
| Operating Margin | -11.0% | 14.2% |
| Net Margin | -9.6% | 8.7% |
| Revenue YoY | -0.6% | 3.2% |
| Net Profit YoY | 59.5% | 12.6% |
| EPS (diluted) | $-0.46 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.0B | $3.8B | ||
| Q3 25 | $2.5B | $3.8B | ||
| Q2 25 | $2.2B | $3.8B | ||
| Q1 25 | $1.8B | $3.7B | ||
| Q4 24 | $2.0B | $3.7B | ||
| Q3 24 | $2.6B | $3.9B | ||
| Q2 24 | $2.4B | $4.0B | ||
| Q1 24 | $2.1B | $3.9B |
| Q4 25 | $-194.0M | $330.0M | ||
| Q3 25 | $184.0M | $398.0M | ||
| Q2 25 | $-294.0M | $420.0M | ||
| Q1 25 | $-443.0M | $322.0M | ||
| Q4 24 | $-479.0M | $293.0M | ||
| Q3 24 | $-1.3B | $383.0M | ||
| Q2 24 | $-865.0M | $58.0M | ||
| Q1 24 | $-186.0M | $296.0M |
| Q4 25 | — | 56.5% | ||
| Q3 25 | — | 59.1% | ||
| Q2 25 | — | 58.9% | ||
| Q1 25 | — | 58.0% | ||
| Q4 24 | — | 56.5% | ||
| Q3 24 | — | 58.5% | ||
| Q2 24 | — | 59.1% | ||
| Q1 24 | — | 57.6% |
| Q4 25 | -11.0% | 14.2% | ||
| Q3 25 | 9.4% | 16.7% | ||
| Q2 25 | -14.5% | 18.0% | ||
| Q1 25 | -29.0% | 14.9% | ||
| Q4 24 | -27.6% | 13.2% | ||
| Q3 24 | -62.9% | 16.8% | ||
| Q2 24 | -20.1% | 3.9% | ||
| Q1 24 | -27.9% | 14.1% |
| Q4 25 | -9.6% | 8.7% | ||
| Q3 25 | 7.4% | 10.6% | ||
| Q2 25 | -13.5% | 10.9% | ||
| Q1 25 | -24.4% | 8.6% | ||
| Q4 24 | -23.5% | 8.0% | ||
| Q3 24 | -51.7% | 9.8% | ||
| Q2 24 | -36.8% | 1.5% | ||
| Q1 24 | -8.9% | 7.6% |
| Q4 25 | $-0.46 | $0.16 | ||
| Q3 25 | $0.42 | $0.21 | ||
| Q2 25 | $-0.95 | $0.22 | ||
| Q1 25 | $-1.44 | $0.17 | ||
| Q4 24 | $-1.57 | $0.16 | ||
| Q3 24 | $-4.34 | $0.20 | ||
| Q2 24 | $-2.82 | $0.03 | ||
| Q1 24 | $-0.61 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $565.0M | $1.1B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-459.0M | $10.8B |
| Total Assets | $22.3B | $27.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $565.0M | $1.1B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $503.0M | $1.1B | ||
| Q1 25 | $626.0M | $1.1B | ||
| Q4 24 | $592.0M | $1.1B | ||
| Q3 24 | $501.0M | $1.1B | ||
| Q2 24 | $568.0M | $1.0B | ||
| Q1 24 | $465.0M | $1.2B |
| Q4 25 | $-459.0M | $10.8B | ||
| Q3 25 | $-317.0M | $10.6B | ||
| Q2 25 | $-504.0M | $10.7B | ||
| Q1 25 | $-262.0M | $10.1B | ||
| Q4 24 | $153.0M | $9.7B | ||
| Q3 24 | $681.0M | $10.6B | ||
| Q2 24 | $2.0B | $10.2B | ||
| Q1 24 | $2.8B | $10.6B |
| Q4 25 | $22.3B | $27.1B | ||
| Q3 25 | $23.0B | $27.2B | ||
| Q2 25 | $23.1B | $27.1B | ||
| Q1 25 | $22.0B | $26.3B | ||
| Q4 24 | $21.8B | $25.6B | ||
| Q3 24 | $23.0B | $26.9B | ||
| Q2 24 | $25.2B | $26.4B | ||
| Q1 24 | $24.3B | $27.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $193.0M | $854.0M |
| Free Cash FlowOCF − Capex | — | $744.0M |
| FCF MarginFCF / Revenue | — | 19.7% |
| Capex IntensityCapex / Revenue | — | 2.9% |
| Cash ConversionOCF / Net Profit | — | 2.59× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.7B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $193.0M | $854.0M | ||
| Q3 25 | $835.0M | $294.0M | ||
| Q2 25 | $346.0M | $621.0M | ||
| Q1 25 | $251.0M | $428.0M | ||
| Q4 24 | $414.0M | $793.0M | ||
| Q3 24 | $894.0M | $249.0M | ||
| Q2 24 | $546.0M | $440.0M | ||
| Q1 24 | $370.0M | $287.0M |
| Q4 25 | — | $744.0M | ||
| Q3 25 | — | $196.0M | ||
| Q2 25 | — | $533.0M | ||
| Q1 25 | — | $249.0M | ||
| Q4 24 | — | $661.0M | ||
| Q3 24 | — | $190.0M | ||
| Q2 24 | — | $350.0M | ||
| Q1 24 | — | $134.0M |
| Q4 25 | — | 19.7% | ||
| Q3 25 | — | 5.2% | ||
| Q2 25 | — | 13.9% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 18.1% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | 8.8% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 3.9% |
| Q4 25 | — | 2.59× | ||
| Q3 25 | 4.54× | 0.74× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | 2.71× | ||
| Q3 24 | — | 0.65× | ||
| Q2 24 | — | 7.59× | ||
| Q1 24 | — | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HTZ
Segment breakdown not available.
KVUE
| Self Care | $1.6B | 42% |
| Essential Health | $1.1B | 30% |
| Skin Health And Beauty | $1.0B | 28% |
